Evidence map›Paper›PMID 26972830›Full record

ArticleScientific reports2016

Metabolic Reprogramming by Hexosamine Biosynthetic and Golgi N-Glycan Branching Pathways.

Michael C Ryczko, Judy Pawling, Rui Chen, Anas M Abdel Rahman, Kevin Yau, Julia K Copeland, Cunjie Zhang, Anu Surendra, David S Guttman, Daniel Figeys and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
9.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 128 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. The Plasma Glycome Differences Between Women with PCOS and Healthy Controls.International journal of molecular sciences · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Alterations in mucosa branchedGut microbes · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Improvement of Spontaneous Locomotor Activity in a Murine Model of Duchenne Muscular Dystrophy by N-Acetylglucosamine Alone and in Combination With Prednisolone.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Food for thought: Nutrient metabolism controlling early T cell development.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Michael C RyczkoLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Ave., Toronto ON M5G 1X5, Canada.
Judy PawlingLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Ave., Toronto ON M5G 1X5, Canada.
Rui ChenOttawa Institute of Systems Biology, Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa ON K1H 8M5, Canada.
Anas M Abdel RahmanLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Ave., Toronto ON M5G 1X5, Canada.
Kevin YauLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Ave., Toronto ON M5G 1X5, Canada.
Julia K CopelandCentre for the Analysis of Genome Evolution &Function, University of Toronto, Toronto ON M5S 3B2, Canada.
Cunjie ZhangLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Ave., Toronto ON M5G 1X5, Canada.
Anu SurendraCentre for the Analysis of Genome Evolution &Function, University of Toronto, Toronto ON M5S 3B2, Canada.
David S GuttmanCentre for the Analysis of Genome Evolution &Function, University of Toronto, Toronto ON M5S 3B2, Canada.
Daniel FigeysOttawa Institute of Systems Biology, Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa ON K1H 8M5, Canada.
James W DennisLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Ave., Toronto ON M5G 1X5, Canada.
University of Toronto · CALunenfeld-Tanenbaum Research Institute · CAMount Sinai Hospital · CADalian Institute of Chemical Physics · CNUniversity of Ottawa · CA

Funding

Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Vanderbilt Mouse Metabolic Phenotyping CenterU2CDK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2016 to 2021
$6.3M
Canadian Institutes of Health Research CCI-117960Canadian Institutes of Health Research MOP-62975Canadian Institutes of Health Research TGF-96121NIDDK NIH HHS DK59637NIDDK NIH HHS U24 DK059637
6 · The paper itself

Abstract

De novo uridine-diphosphate-N-acetylglucosamine (UDP-GlcNAc) biosynthesis requires glucose, glutamine, acetyl-CoA and uridine, however GlcNAc salvaged from glycoconjugate turnover and dietary sources also makes a significant contribution to the intracellular pool. Herein we ask whether dietary GlcNAc regulates nutrient transport and intermediate metabolism in C57BL/6 mice by increasing UDP-GlcNAc and in turn Golgi N-glycan branching. GlcNAc added to the drinking water showed a dose-dependent increase in growth of young mice, while in mature adult mice fat and body-weight increased without affecting calorie-intake, activity, energy expenditure, or the microbiome. Oral GlcNAc increased hepatic UDP-GlcNAc and N-glycan branching on hepatic glycoproteins. Glucose homeostasis, hepatic glycogen, lipid metabolism and response to fasting were altered with GlcNAc treatment. In cultured cells GlcNAc enhanced uptake of glucose, glutamine and fatty-acids, and enhanced lipid synthesis, while inhibition of Golgi N-glycan branching blocked GlcNAc-dependent lipid accumulation. The N-acetylglucosaminyltransferase enzymes of the N-glycan branching pathway (Mgat1,2,4,5) display multistep ultrasensitivity to UDP-GlcNAc, as well as branching-dependent compensation. Indeed, oral GlcNAc rescued fat accumulation in lean Mgat5(-/-) mice and in cultured Mgat5(-/-) hepatocytes, consistent with N-glycan branching compensation. Our results suggest GlcNAc reprograms cellular metabolism by enhancing nutrient uptake and lipid storage through the UDP-GlcNAc supply to N-glycan branching pathway.

Indexed as

3T3-L1 CellsAcetylglucosamineAdministration, OralAge FactorsAnimalsBiosynthetic PathwaysBody WeightCell LineCells, CulturedChromatography, LiquidEnergy MetabolismGastrointestinal MicrobiomeGlucosamineGlucoseGolgi ApparatusHomeostasisAcetylglucosaminealpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseGlucosamineGlucoseLiver GlycogenN-AcetylglucosaminyltransferasesPolysaccharidesUDP-glucosamine

Identifiers

PMID26972830
PMCPMC4789752
OpenAlexW2301452727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.